Veracyte Statistics
Share Statistics
Veracyte has 78.67M
shares outstanding. The number of shares has increased by 1.51%
in one year.
| 78.67M |
| 1.51% |
| 0.46% |
| 99.99% |
| 78.21M |
| 30 |
| n/a |
Short Selling Information
The latest short interest is 9.13M, so 11.6% of the outstanding
shares have been sold short.
| 9.13M |
| 11.6% |
| 12.94% |
| 9.27 |
Valuation Ratios
The PE ratio is 125.48 and the forward
PE ratio is 24.57.
Veracyte's PEG ratio is
-0.96.
| 125.48 |
| 24.57 |
| 6.79 |
| 5.2 |
| 2.58 |
| 47.47 |
| -0.96 |
Financial Ratio History Enterprise Valuation
Veracyte has an Enterprise Value (EV) of 2.84B.
| 6.37 |
| 57.73 |
| 37.82 |
| 44.51 |
Financial Position
The company has a current ratio of 4.73,
with a Debt / Equity ratio of 0.04.
| 4.73 |
| 4.46 |
| 0.04 |
| 1.03 |
| 0.8 |
| 8071 |
Financial Efficiency
Return on Equity is 2.05% and Return on Invested Capital is 1.23%.
| 2.05% |
| 1.86% |
| 1.23% |
| $540.98K |
| $29.29K |
| 824 |
| 0.34 |
| 7.18 |
Taxes
| 1.61M |
| 6.24% |
Stock Price Statistics
The stock price has increased by 9.62% in the
last 52 weeks. The beta is 2.12, so Veracyte's
price volatility has been higher than the market average.
| 2.12 |
| 9.62% |
| 30.16 |
| 32.37 |
| 67.92 |
| 1,436,076 |
Income Statement
In the last 12 months, Veracyte had revenue of 445.76M
and earned 24.14M
in profits. Earnings per share was 0.32.
| 445.76M |
| 289.55M |
| 16.14M |
| 24.14M |
| 49.2M |
| 25.75M |
| 0.32 |
Full Income Statement Balance Sheet
The company has 239.09M in cash and 50.74M in
debt, giving a net cash position of 188.35M.
| 239.09M |
| 50.74M |
| 188.35M |
| -443.98M |
| 1.34B |
| 338.25M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 75.1M
and capital expenditures -11.29M, giving a free cash flow of 63.81M.
| 75.1M |
| -11.29M |
| 63.81M |
| 0.83 |
Full Cash Flow Statement Margins
Gross margin is 64.95%, with operating and profit margins of 3.62% and 5.41%.
| 64.95% |
| 3.62% |
| 5.78% |
| 5.41% |
| 11.04% |
| 3.62% |
| 14.31% |